Targeting HIV: antiretroviral therapy and development of drug resistance
- 1 August 2002
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 23 (8) , 381-388
- https://doi.org/10.1016/s0165-6147(02)02054-0
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Strategies in the design of antiviral drugsNature Reviews Drug Discovery, 2002
- Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors 1 1Edited by J. KarnJournal of Molecular Biology, 2001
- Mechanisms of Viral Membrane Fusion and Its InhibitionAnnual Review of Biochemistry, 2001
- HIV-1 evolution under pressure of protease inhibitors: Climbing the stairs of viral fitnessJournal of Biomedical Science, 1999
- HIV resistance to zidovudine: the role of pyrophosphorolysisDrug Resistance Updates, 1999
- A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors.Journal of Clinical Investigation, 1998
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995